RT Journal Article
SR Electronic
T1 The Use of Transvaginal Ultrasound in Type II Endometrial Cancer
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 858
OP 862
DO 10.1097/IGC.0000000000000423
VO 25
IS 5
A1 Caroline C. Billingsley
A1 Kimberly A. Kenne
A1 Catherine D. Cansino
A1 Floor J. Backes
A1 David E. Cohn
A1 David M. O’Malley
A1 Larry J. Copeland
A1 Jeffrey M. Fowler
A1 Ritu Salani
YR 2015
UL http://ijgc.bmj.com/content/25/5/858.abstract
AB Objective To determine the use of the transvaginal ultrasound (TVUS) in postmenopausal women with type II endometrial cancer.Methods/Materials A retrospective review was conducted for 173 women with pathology proven type II endometrial cancer at a single institution. Those who underwent preoperative TVUS were included, and the following data were obtained: endometrial stripe (EMS) measurement, uterine and/or adnexal findings, and uterine size/volume. Clinicopathologic factors were abstracted. Descriptive and regression analyses were performed.Results Fifty-eight women comprised the cohort, and the median age was 66.5 years (50–85 years). The most commonly reported symptom was postmenopausal bleeding in 53 patients (91.4%). The EMS was reported as thin (⩽5mm) or indistinct in 16 patients (27.5%). Approximately 60% of patients had 1 or more ultrasound abnormalities: intracavitary mass (31%), intracavitary fluid (12.1%), myometrial lesion (31.03%), and adnexal mass (12.1%). Poorly differentiated endometrioid cancer (53.45%) represented the predominant histology. Of the 16 (27.5%) women with a thin/indistinct EMS, 5 women (8.6%) did not have any abnormal ultrasound findings whatsoever.Conclusions Women with type II endometrial cancer had a thin/indistinct EMS on TVUS in approximately 25% of cases. Lack of any ultrasound abnormality, including a thickened EMS, was noted in approximately 10% of patients. The use of TVUS, which has been of value in type I cancer, is limited in type II endometrial cancer. Therefore, endometrial sampling should be included in the evaluation of all women with postmenopausal bleeding, regardless of EMS thickness.